Topical timolol 0.5% gel-forming solution for erythema in rosacea: A quantitative, split-face, randomized, and rater-masked pilot clinical trial.
作者信息
Tsai Jerry, Chien Anna L, Kim Noori, Rachidi Saleh, Connolly Brian M, Lim Hester, Alessi César Sabrina Sisto, Kang Sewon, Garza Luis A
机构信息
Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
出版信息
J Am Acad Dermatol. 2021 Oct;85(4):1044-1046. doi: 10.1016/j.jaad.2021.01.098. Epub 2021 Feb 3.
Abstract
摘要
相似文献
1
Topical timolol 0.5% gel-forming solution for erythema in rosacea: A quantitative, split-face, randomized, and rater-masked pilot clinical trial.0.5%噻吗洛尔凝胶形成溶液治疗酒渣鼻红斑：一项定量、半脸、随机、评估者盲法的试点临床试验。
J Am Acad Dermatol. 2021 Oct;85(4):1044-1046. doi: 10.1016/j.jaad.2021.01.098. Epub 2021 Feb 3.
2
A randomized, controlled, split-face study of topical timolol maleate 0.5% eye drops for the treatment of erythematotelangiectatic rosacea.一项关于0.5%马来酸噻吗洛尔滴眼液治疗红斑毛细血管扩张型酒渣鼻的随机对照半脸研究。
J Cosmet Dermatol. 2021 Dec;20(12):3968-3973. doi: 10.1111/jocd.14347. Epub 2021 Aug 1.
3
Evaluation of topical metronidazole gel in acne rosacea.外用甲硝唑凝胶治疗玫瑰痤疮的评估。
Drug Intell Clin Pharm. 1987 Apr;21(4):346-51. doi: 10.1177/106002808702100410.
4
Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of two randomized, double-blind, and vehicle-controlled pivotal studies.每日一次外用0.5%酒石酸溴莫尼定凝胶治疗中度至重度酒渣鼻面部红斑的疗效和安全性：两项随机、双盲、赋形剂对照关键研究的结果
J Drugs Dermatol. 2013 Jun 1;12(6):650-6.
5
Improvement in facial erythema within 30 minutes of initial application of brimonidine tartrate in patients with rosacea.酒渣鼻患者初次应用酒石酸溴莫尼定后30分钟内面部红斑改善。
J Drugs Dermatol. 2014 Jun;13(6):699-704.
6
A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial.15%壬二酸凝胶与0.75%甲硝唑凝胶局部治疗丘疹脓疱型玫瑰痤疮的比较：一项随机试验的结果
Arch Dermatol. 2003 Nov;139(11):1444-50. doi: 10.1001/archderm.139.11.1444.
7
Assessment of Skin Physiology Change and Safety After Intradermal Injections With Botulinum Toxin: A Randomized, Double-Blind, Placebo-Controlled, Split-Face Pilot Study in Rosacea Patients With Facial Erythema.真皮内注射肉毒毒素后皮肤生理变化及安全性评估：一项伴有面部红斑的酒渣鼻患者面部随机、双盲、安慰剂对照、分面试验性研究。
Dermatol Surg. 2019 Sep;45(9):1155-1162. doi: 10.1097/DSS.0000000000001819.
8
Once-daily topical brimonidine tartrate gel 0·5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies.每日一次局部应用酒石酸溴莫尼定凝胶 0.5%是治疗中重度酒渣鼻面部红斑的一种新方法：两项多中心、随机对照和赋形剂对照研究的结果。
Br J Dermatol. 2012 Mar;166(3):633-41. doi: 10.1111/j.1365-2133.2011.10716.x.
9
Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: a prospective, randomized, double-masked, active-controlled, three-period crossover pilot study.每日一次噻吗洛尔半水合物 0.5%、马来酸噻吗洛尔山梨酸盐 0.5%和通用马来酸噻吗洛尔凝胶形成溶液 0.5%在青光眼和/或高眼压症中的短期耐受性：一项前瞻性、随机、双盲、阳性对照、三周期交叉先导研究。
Clin Ther. 2009 Oct;31(10):2063-71. doi: 10.1016/j.clinthera.2009.10.003.
引用本文的文献
1
Rosacea in Older Adults and Pharmacologic Treatments.老年人玫瑰痤疮及药物治疗
Drugs Aging. 2024 May;41(5):407-421. doi: 10.1007/s40266-024-01115-y. Epub 2024 Apr 23.
2
Rosacea: Pathogenesis and Therapeutic Correlates.酒渣鼻：发病机制与治疗相关性。
J Cutan Med Surg. 2024 Mar-Apr;28(2):178-189. doi: 10.1177/12034754241229365. Epub 2024 Mar 7.
3
Exploring the Pathogenesis and Mechanism-Targeted Treatments of Rosacea: Previous Understanding and Updates.探索酒渣鼻的发病机制及机制导向治疗：既往认识与更新
Biomedicines. 2023 Jul 31;11(8):2153. doi: 10.3390/biomedicines11082153.
本文引用的文献
1
Difference in vasoconstrictors: oxymetazoline vs. brimonidine.血管收缩剂的区别：奥塞米唑啉与溴莫尼定。
J Dermatolog Treat. 2021 Mar;32(2):137-143. doi: 10.1080/09546634.2019.1639606. Epub 2019 Aug 12.
2
Brimonidine effective but may lead to significant rebound erythema.溴莫尼定有效，但可能导致显著的反弹性红斑。
J Am Acad Dermatol. 2014 May;70(5):e109-10. doi: 10.1016/j.jaad.2014.01.853.
3
Once-daily topical brimonidine tartrate gel 0·5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies.每日一次局部应用酒石酸溴莫尼定凝胶 0.5%是治疗中重度酒渣鼻面部红斑的一种新方法：两项多中心、随机对照和赋形剂对照研究的结果。
Br J Dermatol. 2012 Mar;166(3):633-41. doi: 10.1111/j.1365-2133.2011.10716.x.
4
Shortterm "escape" and longterm "drift." The dissipation effects of the beta adrenergic blocking agents.短期“逃逸”和长期“漂移”。β肾上腺素能阻滞剂的消散效应。
Surv Ophthalmol. 1983 Dec;28 Suppl:235-42. doi: 10.1016/0039-6257(83)90138-8.
5
Restoring sensitivity to timolol after long-term drift in primary open-angle glaucoma.原发性开角型青光眼长期漂移后恢复对噻吗洛尔的敏感性。
Invest Ophthalmol Vis Sci. 1990 Feb;31(2):354-8.
Zotero 插件